WO2007038377A2 - Produit de savon therapeutique a protection contre les u.v. - Google Patents
Produit de savon therapeutique a protection contre les u.v. Download PDFInfo
- Publication number
- WO2007038377A2 WO2007038377A2 PCT/US2006/037153 US2006037153W WO2007038377A2 WO 2007038377 A2 WO2007038377 A2 WO 2007038377A2 US 2006037153 W US2006037153 W US 2006037153W WO 2007038377 A2 WO2007038377 A2 WO 2007038377A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- approximately
- cleansing composition
- skin
- zinc oxide
- titanium dioxide
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 17
- 230000006750 UV protection Effects 0.000 title claims description 6
- 229940095696 soap product Drugs 0.000 title description 16
- 239000000203 mixture Substances 0.000 claims abstract description 94
- 239000004615 ingredient Substances 0.000 claims abstract description 41
- 238000005406 washing Methods 0.000 claims abstract description 9
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 132
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 118
- 239000000344 soap Substances 0.000 claims description 90
- 239000011787 zinc oxide Substances 0.000 claims description 66
- 239000004408 titanium dioxide Substances 0.000 claims description 57
- 235000012196 Cedronella canariensis Nutrition 0.000 claims description 45
- 239000004856 Balm of Gilead Substances 0.000 claims description 42
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 37
- 230000000475 sunscreen effect Effects 0.000 claims description 37
- 239000000516 sunscreening agent Substances 0.000 claims description 37
- 235000019804 chlorophyll Nutrition 0.000 claims description 36
- 229930002875 chlorophyll Natural products 0.000 claims description 36
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 36
- 244000144927 Aloe barbadensis Species 0.000 claims description 35
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 35
- 235000011399 aloe vera Nutrition 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 17
- 235000001014 amino acid Nutrition 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 16
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 16
- 239000011707 mineral Substances 0.000 claims description 16
- 235000010755 mineral Nutrition 0.000 claims description 16
- 235000008390 olive oil Nutrition 0.000 claims description 16
- 239000004006 olive oil Substances 0.000 claims description 16
- 235000013343 vitamin Nutrition 0.000 claims description 16
- 239000011782 vitamin Substances 0.000 claims description 16
- 229940088594 vitamin Drugs 0.000 claims description 16
- 229930003231 vitamin Natural products 0.000 claims description 16
- 235000015165 citric acid Nutrition 0.000 claims description 15
- 241000161288 Populus candicans Species 0.000 claims description 13
- 230000004224 protection Effects 0.000 claims description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 12
- 235000005979 Citrus limon Nutrition 0.000 claims description 8
- 244000131522 Citrus pyriformis Species 0.000 claims description 8
- 235000009769 Populus balsamifera subsp. balsamifera Nutrition 0.000 claims description 8
- 230000000844 anti-bacterial effect Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003205 fragrance Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 239000003899 bactericide agent Substances 0.000 claims description 4
- 239000003086 colorant Substances 0.000 claims description 4
- 238000005187 foaming Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 3
- 239000003429 antifungal agent Substances 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims description 2
- 241001458252 Populus x jackii Species 0.000 claims 9
- 238000003287 bathing Methods 0.000 abstract description 2
- 230000037072 sun protection Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 104
- 238000012360 testing method Methods 0.000 description 59
- 240000000078 Cedronella canariensis Species 0.000 description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 18
- 239000007788 liquid Substances 0.000 description 16
- 239000000843 powder Substances 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 206010015150 Erythema Diseases 0.000 description 9
- 231100000321 erythema Toxicity 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000005855 radiation Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 206010042496 Sunburn Diseases 0.000 description 7
- 229960004881 homosalate Drugs 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 230000000774 hypoallergenic effect Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 230000037307 sensitive skin Effects 0.000 description 6
- 230000003068 static effect Effects 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- 208000000453 Skin Neoplasms Diseases 0.000 description 5
- 229940061720 alpha hydroxy acid Drugs 0.000 description 5
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- -1 humectins Substances 0.000 description 5
- 201000000849 skin cancer Diseases 0.000 description 5
- 244000283070 Abies balsamea Species 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 244000062730 Melissa officinalis Species 0.000 description 4
- 235000010654 Melissa officinalis Nutrition 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- 206010067482 No adverse event Diseases 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000865 liniment Substances 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 230000019612 pigmentation Effects 0.000 description 4
- 235000007173 Abies balsamea Nutrition 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- 241000219000 Populus Species 0.000 description 3
- 241000218998 Salicaceae Species 0.000 description 3
- 241000287219 Serinus canaria Species 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- 230000036555 skin type Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000036561 sun exposure Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000944022 Amyris Species 0.000 description 2
- 241001127819 Commiphora gileadensis Species 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical group [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000007256 Nevus Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940126534 drug product Drugs 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 235000004507 Abies alba Nutrition 0.000 description 1
- 244000178606 Abies grandis Species 0.000 description 1
- 235000017894 Abies grandis Nutrition 0.000 description 1
- 235000004710 Abies lasiocarpa Nutrition 0.000 description 1
- 206010068388 Actinic elastosis Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 230000005457 Black-body radiation Effects 0.000 description 1
- 241000208229 Burseraceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000139184 Canarium schweinfurthii Species 0.000 description 1
- 235000003244 Canarium schweinfurthii Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102100026533 Cytochrome P450 1A2 Human genes 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 229940126656 GS-4224 Drugs 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101000855342 Homo sapiens Cytochrome P450 1A2 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 241000720974 Protium Species 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000010460 hemp oil Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical group [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/06—Inorganic compounds
- C11D9/18—Water-insoluble compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/22—Organic compounds, e.g. vitamins
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/22—Organic compounds, e.g. vitamins
- C11D9/26—Organic compounds, e.g. vitamins containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/22—Organic compounds, e.g. vitamins
- C11D9/30—Organic compounds, e.g. vitamins containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/22—Organic compounds, e.g. vitamins
- C11D9/38—Products in which the composition is not well defined
Definitions
- UV ultraviolet
- Solar UV radiation causes damage to cell membranes and the DNA molecules inside the cells. It also helps break down collagen fibers and elastin, which are proteins that are vitally important for maintaining the skin's structural integrity. UV radiation causes collagen to break down faster than with the normal aging process. Repeated overexposure to the sun causes a thickening of the skin that produces a tough, leathery skin and unsightly changes in skin pigmentation. Overexposure to the sun and its UV rays cosmetically harms the skin, causing freckles, wrinkles, premature skin aging, solar lentago, solar elastosis, and pigment coloration changes, among other skin blemishes. As people increasingly engage in the modern outdoor lifestyle, these health and cosmetic concerns become more urgent.
- UVA rays which comprise approximately 90-95% of the sun's ultraviolet light, have a relatively long wavelength in the 320-400 nanometer range. UVA rays are not absorbed by the ozone layer and are the primary cause of initial stages of a tan. UVB rays, with medium wavelength of about 290-320 nanometers, are partially absorbed by the ozone layer and are the primary cause of a sunburn.
- sunscreen products have been developed and widely used for protection • against UVA and UVB rays.
- the skin-care market currently sells sunscreen products generally in two different forms: as chemical absorbers or as physical blockers.
- Chemical sunscreens contain one or more UV absorbing chemical components such as abovenzone, octocrylene, benzophenones, salicylate, and cinnamates. Although they are effective in shielding the body against the sun's effect, they also cause adverse skin reactions. Some studies have also found that chemical sunscreens generate harmful free radicals and may actually increase the risk of cancer. Some commonly used chemical sunscreens also have strong estrogenic actions that may lead to complications.
- physical blockers or inorganic sunscreens physically scatter and reflect UVB and UVA rays.
- Physical sunblocks such as zinc oxide or titanium dioxide, are not absorbed by the skin and are not known to cause health complications.
- sunscreen products can be difficult to apply over the whole body. Even when applied properly, it must be applied repeatedly and in ample amounts. Additionally, a sunscreen lotion may be uncomfortable for some because of the oily/greasy feel it may leave behind. Thus, there is a need for a product that allows its users to apply sunblock on a daily basis in a convenient and easy manner.
- the skin is also the body's largest organ.
- the epidermis which is the outermost layer, functions primarily as a protective barrier, while the dermis is the underlying layer.
- the skin provides the vital function of protecting the body against physical and chemical elements.
- the blood vessels in the skin also regulate body temperature, and the skin functions as an important sensorial tool.
- the skin In addition to providing protection and regulating the body, the skin also functions as a shock absorber and an insulator. No matter the age or skin type, proper skin care also involves proper cleaning, nourishing, moisturizing, and protecting. A good cleanser or soap rids the skin of the dirt and pollutants that accumulate over the course of a day without causing drying or adverse reaction.
- the skin also needs to be nourished with nutrients and moisturizers.
- the skin As an active organ, the skin is also susceptible to damages and ailments. Sunburns caused by overexposure should be treated promptly. Likewise, skin conditions such as eczema, acne, irregular pigmentation and the like should also be treated. Thus, there is a need for a skin product that simultaneously provides therapy and maintenance for healthy skin. Thus, there is a need in the art for an improved skin cleansing composition that safely washes and therapeutically treats the skin, while applying sunblock through the normal use of the soap.
- the cleansing composition of the present invention applies sunscreen protection to the skin through the normal routine of bathing or washing with a bar of soap. As a result, it can be applied to the whole body and face quite efficiently and better suited for use on a daily basis.
- the composition is also suited for frequent use because of the non-greasy, all natural, and hypoallergenic formulation.
- the soap composition of the present invention further comprises ingredients that strengthen and nourish the skin.
- the cleansing composition of the present invention provides additional advantages.
- the present invention allows those with sensitive skin to wear sunscreen protection without forgetting. Additionally, the present invention does not have harsh or unnatural ingredients and thus makes it appropriate for individuals with sensitive skin. Another advantage of the present invention is that it is a therapeutic product.
- a therapeutic product generally heals and nourishes the skin, thereby promoting a healthier skin.
- the soap composition of the present invention also nourishes and cares for the skin by providing various therapeutic ingredients.
- the unique formulation of the present invention provides manifold advantages: it gently cleans the skin, it protects the skin against the sun, and it nurtures and heals the skin.
- the present invention concerns a cleansing composition that applies sunblock to the skin through normal daily use.
- the cleansing composition is preferably in a soap bar form.
- users will generally wash with the soap bar and rinse off with water in the ordinary course of washing.
- the composition of the present invention imparts and leaves behind a UV protectant for the skin.
- the cleansing composition of the present invention also provides therapeutic benefits to the skin.
- the present invention comprises a unique combination of ingredients that provides therapeutic and restorative properties for the skin. Repeated use of the composition of the present invention reduces skin ailments and cosmetic blemishes such as acne, freckles, and age spots.
- the composition is especially useful for those with sensitive and fair skin.
- the all- natural based formulation leaves no noticeable oil or residues that may cause adverse skin reactions. Because the present invention is also gentle for daily use even by those with the most sensitive skin, it can be used regularly without harm or side effect.
- the soap composition of the present invention also preferably does not use any non-natural ingredients and preferably does not use allergic ingredients.
- the present invention comprises a natural soap base.
- glycerin a natural humectant
- glycerin is hypo-allergenic and safe for use on sensitive skin.
- Other hypo-allergenic soap bases may also be used as ' K ⁇ wriln'the'ar ⁇ " '"For example, the soap base may comprise approximately 15- 20 % pure glycerin, to which may be added approximately 7-13% additional lipids.
- vegetable or plant derived soap bases are chosen. Olive oil or coconut oil bases may also be used, but lye derived soap bases are preferably avoided.
- the soap bar composition of the present invention comprises physical sunblocks, titanium dioxide and zinc oxide. These physical sunblocks keep UVA and UVB rays from reaching the skin, and they block the UV rays rather than absorbing them like chemical sunscreens. In preferred embodiments, ultraf ⁇ ne or microfine forms of these physical sunblocks are used. Their small size makes them clear and cosmetically suitable. More preferably, the zinc oxide is in nanospheric form to allow for better blending with the other ingredients of the present invention. Titanium dioxide and zinc oxide also possess therapeutic properties that are beneficial to the skin. Preferably, titanium dioxide and zinc oxide are blended or paired together in making the inventive composition.
- the soap composition of the present invention further comprises the following ingredients: chlorophyll, citric acid, the healing balm of Gilead, aloe vera, vitamins, minerals, olive oil, and amino acids.
- the liquid to powder ratio is balanced to provide for optimal texture, consistency and hardness of the resulting soap product.
- the amount of liquid added is adjusted so that the resulting product will have optimal texture, consistency and hardness of a soap bar as known in the art. If too much powder ingredients are used, for example, the soap product may have inappropriate texture, consistency and hardness.
- Many of the ingredients can be used in either liquid or powder (or solid) forms, and the final consistency, texture and hardness of the soap product should be considered in making the adjustments. As known in the art, different combinations of liquid to powder proportions may be used.
- Chlorophyll for example, may be added in either liquid or powder form. Preferably, chlorophyll is added in liquid form.
- the chlorophyll used in the present invention is preferably made without additives or preservatives. In some embodiments, chlorophyll may be added in both powder and liquid forms. Chlorophyll promotes skin restoration and skin therapy and provides treatment for burns, sunburns, abrasions and skin irritations. It also gives the soap product of the present invention anti-bacterial and detoxifying properties.
- Alpha-hydroxy acids preferably organic acids, and more preferably citric acids are also added in the inventive compound.
- These alpha-hydroxy acids are derived from foods, such as milk, wine, fruits and citrus.
- Citric acids are used at low concentrations, and they help gently exfoliate the skin. It helps remove the outer layer of dead skin cells and thus helps the skin in its natural regenerating process.
- the citric acid helps the skin achieve and maintain a smoother, fresher, younger-looking skin and increases the skin's thickness. Also functioning as a skin moisturizer, the citric acid improves the overall tone of the skin and reduces lines. Since too much alpha-hydroxy acids may render the skin sensitive, low concentrations are added to the present invention.
- the sunscreen in the inventive composition further protects the skin from being damaged by the sun.
- the present invention also comprises the healing balm of Gilead.
- the balm is prepared from one or more of the following plants.
- the Old World balm of Gilead, or Mecca Balsam is a small evergreen tree native to Asia and Africa.
- the American balm of Gilead is a species of poplar, populus candicans of the willow family. Also, balsam poplar varieties may also be use as well as the
- the balm of Gilead is preferably used in liquid form rather than in its bulbous form.
- the balm of Gilead gives the soap composition therapeutic healing properties.
- the balm of Gilead helps disinfect the skin, act as a stringent, treat eczyma and other skin disorders, and relieve dry, scaly and itchy skin.
- the present invention comprises aloe vera, which may be used in powder, juice or gel form.
- the aloe vera is preferably prepared from the whole leaf of the plant. Juice preparations are preferred, and gel forms are the more preferred embodiments.
- the aloe vera provides natural vitamins, minerals, enzymes, minerals, sugars, and other beneficial natural ingredients.
- the aloe vera opens up the pores of the skin, helps repair damaged skin tissues, moisturizes and hydrates the skin, rejuvenates the skin, and helps reduce and prevent skin blemishes and wounds.
- the soap composition of the present invention also comprises all natural vitamins, minerals and amino acids.
- an all-in-one powder multivitamin is used.
- beneficial mineral are provided preferably in low dosage.
- natural amino acids are also included to further help nourish the skin.
- the present invention further comprises olive oil.
- olive oil functions as an emollient and is useful in treating skin ailments such as psoriasis, excema and dermatitus treatment. It also helps keep the skin hydrated and functions as a lotion. It relieves dry skin and reduce scaling and inflammation.
- Optional ingredients for the inventive composition include, among others, lavender, rosemary and other herbs and fragrances, natural oils, rose absolute and other fragrances, plant extracts, water, emulsifiers, bactericides, humectins, colorants, chelating agents, anti-oxidants and foaming improvers.
- the present invention also comprises a method of making the soap bar product of the present invention, wherein the first step involves mixing all of the ingredients, except the titanium dioxide and zinc oxide, with a glycerin soap base.
- the second step involves: first adding the titanium dioxide; and second adding the zinc oxide.
- the present invention concerns a soap product formulated and processed to provide one or more of the following advantageous properties: sunscreen protection through normal use (washing with and rinsing) with the soap product of the present invention; a natural skin absorber that penetrates the skin to a deep level to enhance the skin; nutrients to feed and nourish the skin to create and maintain healthier skin with improved complexion and more abundant collagen; reduction of acne, aging spots, and freckles with consistent use; and a gentle soap product with no harsh additive or unnatural ingredients.
- the present invention also concerns a soap composition with optimal proportions of various ingredients for optimizing SPF rating of the soap. Although it is generally expected that higher amounts of zinc oxide and titanium oxide would lead to higher SPF ratings, it has been found that increasing the amount of zinc oxide and titanium dioxide does not necessarily maximize the sunscreen SPF factor for the soap product.
- the amount of zinc oxide is added in greater proportion than the amount of titanium dioxide.
- the two physical sunblock ingredients, zinc oxide and titanium dioxide are added in following proportions:
- titanium dioxide • approximately 1 portion by weight of titanium dioxide.
- approximately 7 g of zinc oxide is added, and approximately 3 g to 4 g of titanium dioxide is added.
- approximately 0.4 % to 0.6 % by weight of the soap composition is preferably zinc oxide, and approximately 0.15 % to 0.3 % by weight of the soap composition is preferably titanium dioxide. Most preferably, approximately 0.5 % by weight of the soap is zinc oxide, and approximately 0.2
- % by weight of the soap is titanium dioxide.
- the embodiment described below refers to approximate ranges of amounts of individual ingredients used to make approximately 1.36 kg (3 Ib.) preparation of the soap of the present invention. Larger and small preparations may be made as known in the art.
- the present invention concerns a soap base product that comprises physical UV protectants titanium dioxide and zinc oxide, wherein the UV protectants are applied to the skin by using the soap during normal wash.
- the soap composition of the present invention further comprises a soap base, chlorophyll, alpa-hydroxy acids (preferably citric acids), the healing balm of Gilead, aloe vera, multivitamins, minerals, olive oil and amino acids.
- the present invention also optionally comprises ingredients, among others, lavender, rosemary and other herbs and fragrances, and other natural oils, rose absolute and other fragrances, plant extracts, water, emulsifiers, bactericides, humectins, colorants, chelating agents, anti-oxidants and foaming improvers.
- Titanium Dioxide and Zinc Oxide The present invention comprises two sunblock ingredients, titanium dioxide (TiO 2 ) and zinc oxide (ZO). Titanium dioxide and zinc oxide are well known physical UV blocking pigments. Titanium dioxide and zinc oxide are both very gentle on the skin. Zinc oxide, for example, is often used to treat diaper rash in infants and is a known therapeutic agent for the skin. Physical sunblocks such as titanium dioxide and zinc oxide differ from chemical sunscreens in that they are not absorbed by the skin, but rather lie on top of the skin and prevent the UV rays from reaching the skin.
- Microfine or ultrafine forms of titanium dioxide and zinc oxide are preferably used in the present invention.
- Titanium dioxide a micronized version (microfine or ultrafine) is preferably used. Whereas pigmentary titanium dioxide is about 200 nm in size, ultrafine titanium dioxide is approximately 20 nm in size. These small particles are transparent and do not leave a visible residue.
- a micronized version of the TiO 2 is clear and provide equal amount of sunblocking capability.
- TiO 2 is commercially available from various manufacturers.
- One suitable vendor is Kemira.
- TiO 2 from Kemira, UV-TITAN is ultrafine transparent titanium dioxide, which increases protection against ultraviolet radiation and gives special effects in combination with metallic pigments.
- Kemira' s titanium dioxide contains needle and spherical shaped crystals.
- ZnO a micronized (ultrafine, microfine or nanospheric) version is also preferably used. More preferably, ZnO is in nanospheric form. The smaller particle size of the nanospheric form allows for better dispersion and interaction of ZnO with the other ingredients.
- Microfine zinc oxide provides stable and effective protection against ultraviolet radiation. Zinc oxide provides protection against UVB and UVA uniformly protecting from 290 to 380 nm. ZnO does not react with organic sunscreens when irradiated. Additionally, Zinc Oxide also gives the soap composition of the present invention anti-inflammatory qualities and helps calm irritated skin. Furthermore, ZnO also renders the inventive composition a skin protectant and wound healing adjuvant. Because ZnO is not absorbed into the body, it can safely be used with causing side effects.
- NanoActiveTM Zinc Oxide form NanoScale Material, ultrafine and cosmetic grade (formula weight 81.37, catalog number 10-100), is one example.
- Z-COTE® which is a microfine ZnO, may also be used.
- Zinc oxide and the titanium dioxide are preferably paired, blended, or mixed together.
- zinc oxide is added preferably at approximately between 2 g and 20 g, more preferably between approximately 3 and 1O g, and even more preferably between 6 and 8 g. Most preferably, approximately 7 g of zinc oxide is added.
- titanium dioxide For a 1.36 kg preparation of the present invention, between approximately 1 and 14 g of titanium dioxide is preferably added. More preferably, between approximately 2 and 5 g of titanium dioxide is added. Most preferably, approximately 2.5 to 3.5 g of titanium dioxide is added. Chlorophyll
- Chlorophyll is another active ingredient in the present invention, which provides therapeutic characteristics to the soap bar.
- the chlorophyll molecule is chemically similar to hemoglobin, the oxygen carrying element of human blood, except that chlorophyll's central atom is magnesium instead of iron.
- the chlorophyll used in the present invention does not have any additives or preservatives. Chlorophyll can be added in liquid or powder form, more preferably in liquid form.
- chlorophyll promotes skin restoration and provides skin therapy.
- chlorophyll helps the soap product of the present invention treat ulcerative lesions and burns.
- Chlorophyll also helps sooth burned and sunburned skin and provides pain relief, acting as a skin refresher.
- Chlorophyll allows the present inventive compound to accelerate wound healing and stimulate damaged tissue repair. Chlorophyll also helps inhibit the growth of bacteria and therefore helps the soap composition function as a bacterio-static agent. Chlorophyll helps the soap composition provide an environment that interferes with bacterial growth. It also helps stimulate the growth of healthy granuloma tissue and fibroblasts. Furthermore, chlorophyll also helps the soap composition detoxify and deodorize. Thus, chlorophyll promotes wound healing, detoxifies and deodorizes, and inhibits bacterial growth.
- chlorophyll is preferably added at approximately between 5 and 20 ml, and more preferably at approximately between 7 ml and 15 ml. Most preferably, chlorophyll is added at approximately 10 ml.
- Chlorophyll can be obtained from various manufacturers, including Nature's Sunshine. Chlorophyll by Nature's Sunshine contains photosynthetic chlorophyll and is made from alfafa. Any suitable source may be used for making chlorophyll as known in the art.
- the present invention further comprises an alpha-hydroxy acid.
- an alpha-hydroxy acid Preferably citric acid and more preferably lemon juice may be used.
- Alpha- hydroxy acids dissolve the cement that holds dead skin cells together and influences the structure of new stratum corneum being made. When citric acids is added at low concentration, it allows the soap composition to act as a mild exfoliant.
- Citric acid also helps the skin in its natural regenerating process by fading age spots and making the skin more flexible and smoother. Also functioning as skin moisturizers, the citric acid improves the overall tone of the skin and reduces lines and wrinkles.
- lemon juice is preferably added at amounts of approximately between 5 and 25 ml, and more preferably between approximately 10 and 20 ml. Most preferably, citric acid is added at approximately 15 ml.
- the soap bar composition of the present invention further comprises the healing balm of Gilead.
- the balm of Gilead salve is made from one or more of "tne ' following bialms of Gilead: Old World balm of Gilead, Canary Island balm of Gilead or the American balm of Gilead.
- the balm is prepared from resinous juice of these plants.
- the historic Old World balm of Gilead is a small evergreen tree (Commiphora gileadensis or C. opobalsamum) of the family Burseraceae (incense-tree family), which is native to Africa and Asia and a common source of the commercial balm of Gilead.
- the American balm of Gilead is preferably a species of poplar tree (Populus candicans) of the family Salicaceae (willow family) which has large balsamic and fragrant buds.
- the poplar is closely related to, and sometimes considered a variety of, the balsam poplar (P. tacamahaca, P. Nigra and P.
- balsamifera which has also been called balm of Gilead and tacamahac.
- the balm of Gilead may preferably also include the balsam fir and for herbaceous aromatic, shrubby plant (Dracocephalum canariense or Cedronella canariensis) of the family Labiatae (mint family) native to the Canary Islands and cultivated in parts of the United States. Also Abies Balsamea, Balm of Gilead Fir, or American Silver Fir, are names applied to Canadian species. Descriptions of the balm of Gilead from bontanical.com and encyclopedia.com are incorporated herein by reference.
- balm of Gilead include, among others: Balsamum Meccae var. Judiacum; Balsamum Gileadense; Baume de Ia Mecque; Balsamodendrum Opobalsamum; Balessan; Bechan; Balsam Tree; Amyris Gileadensis; Amyris Opobalsamum; Balsumodendron Gileadensis; Protium Gileadense; and Dossemo.
- the balm of Gilead provides therapeutic properties to the soap bar composition of the present invention. It helps disinfect the skin and act as an astringent. It also helps improve and prevent eczyma and other dry skin disorders.
- the balm of Gilead also provides treatments for skin infections, pimples, swellings, blemishes and other skin diseases. It also moisturizes and soothes the skin. Additionally, the balms referred to above pair well with the soap base, glycerin, providing the right texture to maximize sunscreen protection and penetration of the skin.
- the balm of Gilead may be purchased from various commercial sources.
- One example is the balm of Gilead manufactured by Desert Herbals, Populus Candicans.
- the balm of Gilead is added in liquid form. Powdered forms may be used.
- the resinous liquid collected from the buds of the plants is used.
- the balm of liquid used in the present invention is not processed from a different oil or wax.
- the balm of Gilead is derived from Populus Candicans.
- the balm of Gilead used is P. Nigera.
- the source is P. Balsamifera.
- balm of Gilead For a 1.36 kg preparation of the present invention, approximately 2 to 40 ml of balm of Gilead may be added. More preferably, between approximately 5 to 20 ml may be added. Most preferably approximately 5 ml of balm of gilead is added to a 1.36 kg preparation of the present invention.
- the present invention further comprises aloe vera, which may be in liquid, gel or powder form. Liquid or gel forms are preferred.
- the aloe vera ingredient is preferably prepared using the whole leaf. Aloe vera, available commercially from various sources, may be used, and preferably the aloe vera should be prepared without additives or preservatives.
- aloe vera For a 1.36 kg preparation of the present invention, approximately 5 to 45 ml of aloe vera may preferably be added, and more preferably, 10 to 30 ml of aloe vera may be added. Most preferably, approximately 15 ml of aloe vera is added for a 1.36 kg preparation of the present invention.
- Aloe vera itself comprises various components that are beneficial and therapeutic for the skin. (See positivehealth.com). Aloe vera contains vitamins, especially vitamin D and antioxidants vitamin A (beta-carotene), C and E and even traces of vitamin B 12. Aloe vera also contains small amounts of minerals such as calcium, sodium, potassium, manganese, magnesium, copper, zinc, chromium and selenium. As discussed in more detail below, these essential vitamins and minerals are delivered to the skin through the soap bar of the present invention. Additionally, beneficial enzymes such as bradykinase in the aloe vera help reduce inflammation of the skin when applied topically through the soap bar of the present invention.
- beneficial enzymes such as bradykinase in the aloe vera help reduce inflammation of the skin when applied topically through the soap bar of the present invention.
- sugars in the aloe vera function as moisturizers and help detoxify the skin.
- Anthraquinones which are phenolic compounds found in aloe vera, also enhance the soap bar's anti-bacterial and anti-viral properties.
- lignins better allow the aloe vera to be absorbed into the skin.
- Saponins which are soapy substances, have cleansing and antiseptic properties and function as anti-microbial, anti-bacterial, anti-viral, anti-fungal, and anti- yeast agents. Furthermore, small amounts of fatty acids present in aloe vera further give the soap composition anti-inflammatory characteristics. Salicyclic acid, which is also present in aloe vera, acts as anti-inflammatory and anti- bacterial agents! Finally, aloe vera contains 20 out of 22 amino acids, and 7 out of 8 amino acids, which cannot be synthesized by the body.
- Aloe vera allows the present composition to work on damaged skin tissues and cells. It helps the soap composition heal burns, reduce eczema, and relieve skin irritations. Repeated use helps heal skin ulcers, prevents scarring, and rejuvenates the skin. Furthermore, it helps the soap moisture and hydrate the skin and leads to a softer and smoother skin.
- the aloe vera is absorbed into the skin to stimulate fibroblast replication and increases production of collagen and estain fibers. Importantly, aloe vera is hypo-allergenic and is generally safe for topical application.
- Additional ingredients of the soap bar composition comprise vitamins, minerals, and amino acids.
- these ingredients are added in powder form, but may also be added in liquid form.
- approximately 4 to 16 g of a mixture of vitamins, minerals, and amino acids are added. More preferably approximately 8 g of a mixture of vitamins, mineral and amino acids are added to a 1.36 kg preparation of the present invention.
- an all purpose multi-ingredient formulation may be used.
- the vitamin should preferably include A, C, D, E, K, Bl, B2, Niacin, B6, B 12, folic acid, biotin, and others, one or more of these vitamins may also be missing.
- the vitamins in the soap composition provide added skin nutrition, replenish the skin with lost vitamins, reduce environmental effects on the skin, and help reverse signs of skin aging.
- the soap composition of the present invention also comprises one or more minerals, such as Ca, Fe, P, Mg, Zn, Se, Cu, among others.
- natural amino acids are also added to the soap composition. Although naturally made amino acids are preferred, synthetic amino acids may also be used.
- Glycerin is the preferred soap base in making the soap composition of the present invention. Glycerin acts as a natural humectant. Glycerin is hypo- allergenic and safe for use on sensitive skin. Other hypo-allergenic soap bases may also be used as known in the art. The soap base may comprise, for example, approximately 15-20 % pure glycerin, to which may be added approximately 7- 13% additional lipids.
- vegetable or plant derived soap bases are chosen.
- Olive oil or coconut oil bases may also be used.
- Hemp oil and animal milk may also serve as the soap base.
- Lye derived soap bases are preferably not used.
- the soap composition of the present invention may also comprise one or more of the ingredients such as herbs or fragrance, oils or fats, plant extracts, water, emulsifiers, bactericides or anti-viral or anti-fungal agents, humectants, colorants, anti-oxidants, foaming improvers, and more.
- the ingredients such as herbs or fragrance, oils or fats, plant extracts, water, emulsifiers, bactericides or anti-viral or anti-fungal agents, humectants, colorants, anti-oxidants, foaming improvers, and more.
- care should be taken to not add allergic ingredients. Additional ingredients to facilitate the soap function may also be incorporated as known in the art.
- the first step comprises mixing all of the ingredients (minus TiO2 & Zinc) in a professional quality glycerin soap base.
- Various commercially available soap making kits may be used.
- TiO2 is added to the soap mixture, and then second, zinc oxide is added.
- the present invention also concerns a soap composition with optimal proportions of various ingredients for optimizing SPF rating of the soap.
- the amount of zinc oxide is added in greater proportion than the amount of titanium dioxide.
- the two physical sunblock ingredients were used with the following proportions: • approximately 2 portions by weight of zinc oxide; to
- titanium dioxide • approximately 1 portion by weight of titanium dioxide In a 1.36 kg preparation, preferably, approximately 6-8 g of ZnO and approximately 4-5 g of titanium dioxide is added.
- Test 1 Batch No. 1 , "Not In Use” Test
- test material Upon arrival at AMA Laboratories, Inc., the test material was assigned a unique laboratory code number and entered into a daily log identifying the lot number, sample description, sponsor, date received and testes requested. Five subjects were tested. The subjects' ages ranged between 23 and 59.
- Standards of exclusion from the study were: individuals who are under a doctor's care; individuals who are currently taking any medication (topical or systemic) that may mask or interfere with the test results; subjects with a history of any form of skin cancer, melanoma, lupus, psoriasis, connective tissue disease, diabetes or any disease that would increase the risk associated with study participation; individuals diagnosed with chronic skin allergies; individuals with a history of adverse effects upon sun exposure; female volunteers who indicate that they are pregnant or lactating; individuals with blemishes, nevi, sunburn, suntan, scars, moles, active dermal lesions or uneven pigmentation in the test sites; and individuals with known hypersensitivity to any sunscreen products.
- Institutional Review Board A trained technician performed a physical examination of the subjects' back to determine if study eligibility criteria were satisfied.
- the Institutional Review Board followed reference, CTR Title 21 Part 56, Subparts A, B, C, and D.
- the IRB of AMA Laboratories, Inc. consisting of five or more individuals, chosen from within the company for technical expertise and from local community for lay interaction.
- the light source employed was a 150 watt Xenon Arc Solar Simulator (Solar Light Co., Philadelphia, PA, Model 14S or Model 16S) having a continuous emission spectrum in the UVB range from 290 to 320 nm.
- Xenon arc is selected on the basis of its black body radiation temperature of 6000° K which produces continuous UV spectra (all wavelengths) substantially equivalent to that of a natural sunlight (Berger, D.S.: Specification and Design of Solar Ultraviolet Simulators, J. Invest, Dermatol. 53: 192-199, 1969).
- the device was equipped with a dichroic mirror (which reflects all radiation below 400nm) and works in conjunction with a lmm thick Schott Wg- 320 filter (which absorbs all radiation below 290nm) to produce simulation of the solar UVA-UVB spectrum.
- a lmm thick UG 11 filter black lens
- UVB radiation was monitored continuously during exposure using a Model DCS-I Sunburn UV Meter/Dose Controller System (Solar Light Co.) formerly known as the Robertson-Berger Sunburn Meter (R-B meter). Measurements were taken at a position within 8mm from the surface of the skin.
- the field of irradiation was lcm in diameter.
- the solar simulator was allowed a warm up time of at least 15 minutes before use and power supply output was recorded.
- the UV exposures for test material, 8% homosalate standard were calculated from previously determined MED and the intended SPF as follows.
- SPF 4 MED times 0.64x, 0.8Ox, 0.9Ox. 1.0Ox, UOx, 1.25x, and 1.56x.
- SPF 15 MED times 0.69x, 0.83x, 0.91x, 1.0Ox, 1.09x, 1.2Ox and 1.44x, where x equals the expected SPF of the product.
- Deviation From Protocol Prior to application of the test sample (AMA Lab No.: K-7285), it was allowed to dissolve in water, such that it was diluted to a concentration of 50%. The prepared solution was then delivered to the site at a dosage of 4.0 mg/cm 2 .
- the protected site received a series of seven UV exposures based upon previously determined MED.
- This test was additionally modified to include a flesh tone background more nearly approaching actual use conditions, wherein erythematous skin is graded according to intensity.
- SPF and PCD The mean SPF value (x) was calculated using a minimum of 20 evaluable subjects per formulation. The standard deviation was determined (s).
- the label SPF for panels using a minimum of 20 evaluable subjects was the largest whole number less the mean SPF minus A.
- Label SPF Mean SPF - A The Product Category Designation (PCD) 5 for labeling purposes, was assigned based on the mean SPF and PCD ranking according to the reference. Classifications may be High, Moderate, or Minimal. Because only five test panelists were included in this study, no PCD was assigned.
- PCD Product Category Designation
- Panelist's results were rejected and the panelist replaced if: 1) An exposure series fails to elicit and MED response on the untreated skin, and the test is considered a technical failure even if the MED response is observed in the protected site; 2) The responses on the protected are randomly absent, indicating uneven product spreading, non-constant light irradiance or unstable product; and 3) All exposures in a series of elicit responses - thus prohibiting any MED calculation.
- Test 2 Batch No. 1. "In Use" Test
- Test 3 Batch No. 2, "Not In Use” Test
- Test 1 A "Not In-Use" evaluation procedure was followed as in Test 1. Prior to application of the test sample, it was allowed to dissolve in water, such that it was diluted to a concentration of 50%. The prepared solution was then delivered to the " site at a'dosage of ' 4.0 mg/cm 2 . Otherwise, same protocols were followed as in the previous tests.
- Test 4 Batch No. 2. "In Use" Test In Test No. 4, Batch No. 2 (referred to as Sunscreen Soap 2 and assigned
- AMA Lab No.: K-7598 was subjected to an "In Use" Test.
- the subjects tested were again five people, ranging in age from 20 to 53, who were all Caucasian females. No adverse effects or unexpected reactions of any kind were observed on any of the subjects.
- An "In-Use” evaluation procedure was followed for this test, whereby study participants were instructed to lather the test material on the forearm test sites and rinse in a manner consistent with which they would typically was with a soap product. Their formearms were then exposed to UV rays from the solar simulator. Otherwise, same protocols were followed as in the previous tests.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Abstract
Composition de nettoyage à protection solaire pour la peau, en utilisation quotidienne normale pour le bain, le lavage ou le nettoyage du corps ou de la face. Cette composition présente une combinaison unique d'éléments à propriétés thérapeutiques et réparatrices pour la peau.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/234,097 | 2005-09-26 | ||
| US11/234,096 | 2005-09-26 | ||
| US11/234,096 US7569210B2 (en) | 2005-09-26 | 2005-09-26 | Therapeutic soap product with UV protection |
| US11/234,097 US7700079B2 (en) | 2005-09-26 | 2005-09-26 | Therapeutic soap product with UV protection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007038377A2 true WO2007038377A2 (fr) | 2007-04-05 |
| WO2007038377A3 WO2007038377A3 (fr) | 2007-12-27 |
Family
ID=37900337
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2006/037153 WO2007038377A2 (fr) | 2005-09-26 | 2006-09-22 | Produit de savon therapeutique a protection contre les u.v. |
| PCT/US2006/037152 WO2007038376A2 (fr) | 2005-09-26 | 2006-09-22 | Produit de savon therapeutique a protection contre les u.v. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2006/037152 WO2007038376A2 (fr) | 2005-09-26 | 2006-09-22 | Produit de savon therapeutique a protection contre les u.v. |
Country Status (1)
| Country | Link |
|---|---|
| WO (2) | WO2007038377A2 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340587A (en) * | 1985-05-22 | 1994-08-23 | Liposome Technology, Inc. | Liposome/bronchodilator method & System |
| US6217852B1 (en) * | 1998-08-15 | 2001-04-17 | Skinnovative Dermatologic Concepts, L.L.C. | Personal cleansing compositions having photoprotective agents |
| CA2251457A1 (fr) * | 1998-10-23 | 2000-04-23 | Norman Huner | Compositions comprenant des composes d'origine naturelle tires de plantes, d'algues et de cyanobacteries pour la protection contre les rayons solaires |
| US20050124705A1 (en) * | 2002-03-28 | 2005-06-09 | Beiersdorf Ag | Cosmetic or pharmaceutical, low-viscosity oil-in-water emulsions containing phospholipids |
-
2006
- 2006-09-22 WO PCT/US2006/037153 patent/WO2007038377A2/fr active Application Filing
- 2006-09-22 WO PCT/US2006/037152 patent/WO2007038376A2/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007038376A2 (fr) | 2007-04-05 |
| WO2007038377A3 (fr) | 2007-12-27 |
| WO2007038376A3 (fr) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7700079B2 (en) | Therapeutic soap product with UV protection | |
| US7977290B1 (en) | Body cleansing composition | |
| JP2003515615A (ja) | 治療用抗菌剤組成物 | |
| CA2639525A1 (fr) | Composition topique pour la protection et/ou le traitement contre les lesions cutanees liees au rayonnement | |
| KR102083294B1 (ko) | 피부재생 효과를 갖는 미선나무 추출물 및 그 추출물을 함유하는 피부재생용 조성물 | |
| CN111991257A (zh) | 一种防晒增效组合物及其在制备化妆品中的应用 | |
| US20060083708A1 (en) | Composition using mineral salts for cosmetic or therapeutic treatment | |
| Patil et al. | A review on: standerdization of herb in new era of cosmaceuticals: herbal cosmetics | |
| CN101507693A (zh) | 婴儿用护臀霜 | |
| CN113679640A (zh) | 一种天然滋养净肤护肤祛痘洁面凝露及其制备方法 | |
| WO2004071500A1 (fr) | Produit cosmetique rajeunissant et cicatrisant, son procede de production et ses utilisations | |
| US7569210B2 (en) | Therapeutic soap product with UV protection | |
| KR101252560B1 (ko) | 봉숭아 추출물을 함유하는 여드름 개선용 화장료 조성물 | |
| CN115282104B (zh) | 一种植物复合提取物、抗敏剂及它们的制备方法和应用 | |
| US20110177014A1 (en) | Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection | |
| CN116869878A (zh) | 防晒组合物和防晒底妆产品 | |
| Dave et al. | Formulation and Evaluation of Herbal Face Scrub containing Coffea arabica Linn, Myristica fragrans, and Lens culinaris as an Antioxidant and Antiseptic Activity | |
| RU2671511C1 (ru) | Косметическая композиция для ухода за волосами и кожей головы (варианты) | |
| Sehgal et al. | Formulation and evaluation of anti-acne herbal facewash | |
| WO2007038377A2 (fr) | Produit de savon therapeutique a protection contre les u.v. | |
| Dutt | A study of patenting activity in Aloe vera | |
| CN106821933A (zh) | 一种复合植物精油防晒霜的制备方法 | |
| EP2650004B1 (fr) | Obtention d'extraits normalisés de la plante connue sous le nom de "cuachalalate" (amphipterygium adstringens) et leurs applications en tant qu'agents de protection solaire | |
| KR101033814B1 (ko) | 비누풀 추출물을 함유하는 블랙헤드 제거용 화장료 조성물 | |
| Tiware et al. | A review on herbal face wash |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06815274 Country of ref document: EP Kind code of ref document: A2 |